FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · point in time

Sio Gene Therapies Inc.: cash_and_restricted_cash

One fact, its scope and the complete path back to the official record.

Period: as of 2022-03-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/67e5e22f-9f8a-4581-adc2-7e9e0a5c5cd6

Reported value

$64.913M{"amount": 64913000, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "currency": "USD"}
Entity
Sio Gene Therapies Inc.
Metric
cash_and_restricted_cash
Period
as of 2022-03-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001636050-22-000035 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T16:49:26.163189+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001636050/cash-and-restricted-cash/2022-03-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.